AzTrials
AzTrials

Parkinson DiseaseNCT05790759

Effect of Haptic Cueing on Long-Range Autocorrelations in Parkinson's Disease Gait Variability

A study testing No cueing versus Haptic cueing versus Auditory cueing during parkinson's disease gait in people with Parkinson Disease and Gait, Unsteady, run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain at 2 sites in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Parkinson's Disease (PD) patients suffer from gait impairments responsible for falls and bad quality of life: reduced speed and stride length, randomness in the temporal organization of stride duration variability (reduced Long-Range Autocorrelations (LRA)). Read more about this study

Who is it for?
Any age
Conditions the study is for
Parkinson Disease, Gait, Unsteady
What is being tested?
No cueing versus Haptic cueing versus Auditory cueing during parkinson's disease gait
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
2 sitesBelgium
Study dates
1 Jan 2020to 15 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Idiopathic PD according to the UK Brain Bank Criteria
  • modified Hoehn \& Yahr scale <= 3
  • Mini-Mental State Examination > 24/30
  • Ability to walk 256 consecutive strides

Who cannot join

  • Other pathology interacting with gait
  • Significant hearing problems not allowing to hear the auditory cueing
  • Significant somatosensory problems not allowing to feel the haptic cueing on the skin

Trial locations and contacts

2 sites in 1 country.

Belgium2 sites
  • Cliniques Universitaires Saint Luc

    Brussels, 1200

  • Cliniques Universitaires Saint-Luc

    Brussels, 1200

Other trials in Belgium

About this study

Official title: Effect of Rhythmic Haptic Stimulations on Long-Range Autocorrelations in Parkinson's Disease Gait Variability : A Comparison With Auditory Stimulations

Parkinson's Disease (PD) patients suffer from gait impairments responsible for falls and bad quality of life: reduced speed and stride length, randomness in the temporal organization of stride duration variability (reduced Long-Range Autocorrelations (LRA)). For years, auditory cueing has been used to modulate PD gait and its effect on LRA is known. Less is known regarding the effects of haptic cueing on PD gait and especially on LRA. This pilot study will compare the spatio-temporal gait parameters and LRA of PD patients tested under three conditions: walking without cueing, walking with auditory cueing and walking with haptic cueing by means of rhythmic vibrations on the patients' wrists.

Read the detailed description
  1. BACKGROUND Parkinson's disease (PD) is the second most common degenerative neurological disease. PD induces gait disorders that lead to increased risk of falls. These falls seriously affect patients' quality of life and generate significant health care costs. Unfortunately, gait disorders do not respond well to drug treatments and their management is mainly based on rehabilitation treatment. The rehabilitation approach comprises two steps: a functional assessment of locomotor capacities followed by completion of a therapeutic physical exercise program. Like heart rate, stride duration varies in the short and long term according to a complex dynamic of temporal variations. These variations present long-range autocorrelations (LRA): the stride duration does not vary randomly but in a structured way. The study of LRA is based on complex mathematical methods requiring recording of at least 256 consecutive gait cycles. LRA are altered in PD patients whose gait rhythm is excessively random. Alteration of LRA is correlated with neurological impairments (Hoehn \& Yahr scale and UPDRS) and patients' locomotor stability (ABC scale \& BESTest). Measurement of LRA would be the first available objective and quantitative biomarker of stability and risk of falling in patients with PD. Guidelines concerning rehabilitation programs for PD patients are based on education (prevention of falls and inactivity,...), physical exercises, functional training (double task, complex tasks,...), learning, and adaptation strategies such as the use of rhythmic sensory cueing. Auditory Cueing (AC) has been used for years for clinical and research purposes and its effects on spatio-temporal gait parameters and LRA are known. Less is know regarding Haptic/Somatosensory Cueing (HC). A few research were conducted to study the influence of HC on PD spatio-temporal gait parameters but to the best of our knowledge, none has yet addressed its effects on LRA. The aim of this present study was to compare PD saptio-temporal gait parameters and LRA under three conditions : walking without cueing, walking with AC and walking with HC.
  2. METHODS 2.1 Participants : 10 patients suffering from idiopathic Parkinson's Disease were recruited from the local community and from the Neurology and the Physical and Rehabilitation Medicine outpatient clinics of the Cliniques universitaires Saint-Luc (Woluwe-Saint-Lambert, Belgium).

2.2 Functional assessment: Before the expermientations starts, all participants underwent a non harmful assessment including clinical tests and questionnaires

PD patients: Age, height, weight, sex, most affected side, Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS), Mini Balance Evaluation Systems Test (Mini-BESTest), Simplified version of the Activities-specific Balance Confidence Scale (ABC-Scale), modified Hoehn \& Yahr scale, Mini Mental State Examination (MMSE).

2.3 Procedure : Every participants walked in three conditions in a randomized order. Each condition lasted ±10 minutes in order to get 256 gait cycles mandatory to assess the presence of LRA using the evenly spaced averaged version of the Detrended Fluctuations Analysis (DFA).

The first condition was the control condition (CC), patients walking without any cueing on a rectangular track with rounded corner of 63.2 meters in CUSL at their comfortable walking speed.

The second condition was the Auditory Cueing Condition (ACC) and consisted in walking on the same rectangular track using auditory cueing by the mean of a smartphone app called Soundbrenner. This app allowed to precisely deliver rhythmic auditory stimulations through earphones paced 10% faster than each patient's preferred step frequence assessed before the experiment.

The last condition was the Haptic Cueing Condition (ACC) and consisted in walking on the same rectangular track using haptic cueing by the mean of a vibratory device called Soundbrenner Pulse and attached to each patient's wrist located on their most affected side. The Soundbrenner app on the smartphone was connected to the Soundbrenner Pulse by Bluetooth to deliver rhythmic vibratory stimulations also paced 10% faster than each patient's preferred step frequence, the same frequence as during ACC.

2.4 Data acquisition: Two Inertial Measurement Units (IMU) (IMeasureU Research, VICON, USA) were taped on patients' both lateral malleoli. This system allowed to record ankle accelerations at 500 Hz. The data were then put on a computer and each peak of acceleration, corresponding to each heel strike, was detected by software internally developed to determine all stride durations.

2.5 Gait assessment: Data were extracted from 256 consecutive gait cycles which is required for LRA computation.

2.5.1 Spatiotemporal gait variables:

Mean gait speed, gait cadence and stride length were measured as follow:

Mean gait speed (m.s-1) = Total walking distance (m)/ Acquisition duration (s) Gait cadence (#steps.min-1) = Total number of steps (#)/Acquisition duration (min) Step length (m) = Gait speed (m/s)*60/Gait cadence (steps/min)

2.5.2 Stride duration variability : Stride duration variability can be assessed 2 ways: in terms of magnitude or in terms of organization (how stride duration evolves across consecutive gait cycles).

2.5.2.1 Magnitude of the stride duration variability : To determine the effect of the RAS on the magnitude of the stride duration variability during 256 gait cycles, the mean, the standard deviation (SD) and the coefficient of variation (CV = [SD/mean] * 100) were assessed.

2.5.2.2 Temporal organization of the stride duration variability : Temporal organization of stride duration variability were assessed by LRA computation using the evenly spaced averaged version of the Detrended Fluctuation Analysis (DFA) to obtain α exponent. The presence of LRA can be shown with α exponent values between 0.5 and 1.

Data were treated by the mean of CVI Labwindows (C++).

2.6 Statistical analyses : Statistical analyses were conducted using Sigmaplot 13. If the normality test passed, a one-way repeated measures ANOVA was applied to determine the effect of the various walking condition on spatiotemporal gait parameters (gait speed, gait cadence, stride length) and on linear and nonlinear measures of stride duration variability (CV, SD, H and α exponents). If a significant difference between groups was detected with the ANOVA, a Holm-Sidak post hoc test was performed to compare each mean with the other means to isolate the groups from each other. Effect size between conditions regarding all parameters was assessed using Cohen's d.

Being tested
No cueing versus Haptic cueing versus Auditory cueing during parkinson's disease gait
Keywords
Parkinson's Disease, Gait, Long-Range Autocorrelations, Cueing, Rhytmic stimulations
Medical subject headings
Parkinson Disease, Gait Disorders, Neurologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No cueing versus Haptic cueing versus Auditory cueing during parkinson's disease gaitOther

    Patients walked in three conditions in a randomized order. During control condition, patients walked without cueing on a rectangular track of 63.2 meters at their comfortable gait speed. During Auditory Cueing Condition (ACC) patients walked on the same track using auditory cueing by the mean of a smartphone app called Soundbrenner thath deliverered rhythmic auditory stimulations through earphones paced 10% faster than each patient's preferred step frequence. During Haptic Cueing Condition (HCC) patients walked on the same track using haptic cueing by the mean of a vibratory device called Soundbrenner Pulse and attached to each patient's wrist located on their most affected side. The Soundbrenner app on the smartphone was connected to the Soundbrenner Pulse by Bluetooth to deliver rhythmic vibratory stimulations also paced 10% faster than each patient's preferred step frequence, the same frequence as during ACC.

Study groups in NCT05790759
Study groupRoleWhat they receive
PD patientsExperimentalSee inclusion criteria in the right section. See procedures in the the right section.
Receives: Other: No cueing versus Haptic cueing versus Auditory cueing during parkinson's disease gait

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Long-Range Autocorrelations

    Long-Range Autocorrelations computation using the evenly spaced version of the Detrended Fluctuations Analysis

    Measured: Change from baseline in long-range autocorrelations during each intervention condition (3 x 10 min walking)

Secondary outcomes (4)
  1. Mean Gait Speed

    otal walking distance (m)/ Acquisition duration (s)

    Measured: Change from baseline in mean gait speed during each intervention condition (3 x 10 min walking)

  2. Step Length

    Gait speed (m/s)*60/Gait cadence (steps/min)

    Measured: Change from baseline in step length during each intervention condition (3 x 10 min walking)

  3. Gait Cadence

    Total number of steps (#)/Acquisition duration (min)

    Measured: Change from baseline in gait cadence during each intervention condition (3 x 10 min walking)

  4. Coefficient of variation of stride duration

    [SD/mean stride duration] * 100

    Measured: Change from baseline in coefficient of variation during each intervention condition (3 x 10 min walking)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2023
  2. Study start1 Jan 2020
  3. Primary completion15 Mar 2020
  4. Study completion15 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Model description
One group of patients underwent all experimental conditions once
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05790759
Sponsor's protocol ID
NMSK - Lheureux 03
Status last verified
Mar 2023
First submitted
18 Nov 2021
Last updated
30 Mar 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: IPD could be shared if asked. Anonymized data are available.

Publications

  • Lheureux A, Lejeune T, Doncev I, Jeanne A, Stoquart G. Comparison of the effects of rhythmic vibrotactile stimulations and rhythmic auditory stimulations on Parkinson's disease patients' gait variability: a pilot study. Acta Neurol Belg. 2024 Feb;124(1):161-168. doi: 10.1007/s13760-023-02360-5. Epub 2023 Aug 19.

    PubMed 37597161

Questions about this trial

What is this clinical trial studying?

A study testing No cueing versus Haptic cueing versus Auditory cueing during parkinson's disease gait in people with Parkinson Disease and Gait, Unsteady, run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain at 2 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Long-Range Autocorrelations (time frame: Change from baseline in long-range autocorrelations during each intervention condition (3 x 10 min walking)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05790759, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in